At Enhance.MD, care plans focus on body composition, metabolic health, and sustainable results not just the number on the scale
Some plans provide broad coverage for GLP-1 medications such as Wegovy or Ozempic, while others restrict coverage to diabetes-related prescriptions or exclude weight loss medications entirely
Presented for research literature review only Keene BW (1991)
Patients experiencing persistent fatigue or malaise should ensure adequate caloric intake despite reduced appetite, as excessive caloric restriction can worsen systemic symptoms
Because the program is lab-guided, your clinician can determine whether this combination, another peptide, or a different approach entirely best fits your goals and your physiology
Prior authorization is typically required for Zepbound coverage with Cigna